Pulmonary fungal infections after bone marrow transplantation.
Of 319 pediatric patients treated with bone marrow transplantation (BMT) during a 10-year period, 27 developed pulmonary fungal infections (PFI). Only 2 patients (7%) survived. Twenty-three patients (85%) had been treated with systemic antifungal therapy immediately before or at the time of diagnosis. Nineteen patients (70%) were neutropenic, and 4 of the 8 patients who were not neutropenic were being treated with systemic steroids for graft vs. host disease (GVHD). Seven patients (26%) died within 7 days of diagnosis. The diagnosis was made ante-mortem in 9 patients (33%). Radiographic abnormalities were variable. At the onset of chest X-ray (CXR) change, the pulmonary infiltrates were unilateral in 14 patients (52%) and, at diagnosis, bilateral in 18 (66%). At diagnosis the infiltrates were interstitial in 3 patients (11%), alveolar in 20 (74%) and mixed in 4 (15%). Six patients (22%) developed cavitary lesions. The infecting agents were Aspergillus in 21 patients (78%), Candida in 7 (26%), Mucormycosis in 3 (11%), and Fusarium in 1 (4%). Five patients (19%) had mixed fungal infections and 7 (26%) had concurrent cytomegalovirus (CMV) pulmonary infections. Although the radiographic changes are often nonspecific in PFI, alveolar or nodular infiltrates in neutropenic patients or in those being treated for GVHD should strongly suggest a fungal etiology.
Allan
B T
BT
Department of Diagnostic Radiology, University of Minnesota Medical School, Minneapolis.
Patton
D
D
Ramsey
N K
NK
Day
D L
DL
D001228:Aspergillosis / Q000209:etiology; D016026:Bone Marrow Transplantation; D002177:Candidiasis / Q000209:etiology; D006801:Humans; D008172:Lung Diseases, Fungal / Q000209:etiology*; D009091:Mucormycosis / Q000209:etiology; D010372:Pediatrics; D011183:Postoperative Complications; D012189:Retrospective Studies